Transthyretin Cardiac Amyloidosis Fellowship Grant

Eligible Applicants

Additional Requirements

Eligibility is restricted to accredited, U.S.-based academic institutions capable of offering fellowship programs in the specified field of ATTR cardiac amyloidosis. The grant will be awarded to the institution rather than an individual. To qualify, fellowship programs must emphasize independent research and strong mentoring programs. Institutions must ensure that any fellow receiving grant funds is a U.S. worker, which includes U.S. citizens, permanent residents, refugees, asylees, or those holding appropriate non-immigrant visa statuses authorizing employment in the U.S. Importantly, grant funds cannot be used for overhead or indirect costs, and no part of the fellowship can be billed as patient care. Additionally, compliance with the U.S. Physician Payments Sunshine Act and other transparency law requirements is mandatory.

Geographic Eligibility

All